Density and location of CD3+ and CD8+ tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma

被引:51
作者
Zhou, Chen [1 ,2 ]
Wu, Yaping [1 ]
Jiang, Lei [1 ]
Li, Zhongwu [3 ]
Diao, Pengfei [1 ]
Wang, Dongmiao [1 ]
Zhang, Wei [4 ]
Liu, Laikui [1 ,4 ]
Wang, Yanling [1 ]
Jiang, Hongbing [3 ]
Cheng, Jie [1 ,3 ]
Yang, Jianrong [1 ,3 ]
机构
[1] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Wuxi, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Dept Oral & Maxillofacial Surg, Affiliated Stomatol Hosp, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Dept Oral Pathol, Sch Stomatol, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
CD3; CD8; oral squamous cell carcinoma; prognosis; tumor-infiltrating lymphocytes; BREAST-CANCER; NECK-CANCER; SURVIVAL; HEAD; TIL;
D O I
10.1111/jop.12698
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BackgroundTumor-infiltrating lymphocytes (TILs) are regarded as adaptive immune response of the host to cancer cells and valuable prognostic factors. Here, we sought to characterize the densities and locations of CD3(+) and CD8(+) TILs in primary oral squamous cell carcinoma (OSCC) samples and assess their clinicopathological and prognostic significance. MethodsA total number of 169 OSCC samples from 2 independent patient cohorts (Nanjing cohort, 93 cases; Wuxi cohort, 76 cases) were retrospectively collected. The numbers of CD3(+) and CD8(+) TILs at tumor center (CT) and invasive margin (IM) of OSCC were identified by immunohistochemistry and calculated. The optimal cutoff values for CD3(+) and CD8(+) TILs to stratify patients were determined by X-tile software in Nanjing cohort and further utilized in Wuxi cohort. The associations between CD3(+)/CD8(+) TILs and clinicopathological parameters or patient survival were assessed. The prognostic values of CD3(+)/ CD8(+) TILs were evaluated by Cox regression analyses. ResultsCD3(+) and CD8(+) TILs were identified at both CT and IM and enriched at IM. High density of CD3(+) TILs at IM (CD3 IM) was significantly associated with increased overall and disease-specific survival (P<.05). High density of CD8(+) TILs at CT (CD8 CT) was significantly associated with increased overall but not disease-specific survival. Moreover, CD3 IM and CD8 CT were identified as independent prognostic factors for patient survival. ConclusionsOur findings provide further evidence to support the prognostic values of CD3(+) and CD8(+) TILs for OSCC, suggesting that TIL subsets might be viable biomarkers and therapeutic targets with translational significance.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 30 条
[1]   Association between CD8+T-cell infiltration and breast cancer survival in 12 439 patients [J].
Ali, H. R. ;
Provenzano, E. ;
Dawson, S-J ;
Blows, F. M. ;
Liu, B. ;
Shah, M. ;
Earl, H. M. ;
Poole, C. J. ;
Hiller, L. ;
Dunn, J. A. ;
Bowden, S. J. ;
Twelves, C. ;
Bartlett, J. M. S. ;
Mahmoud, S. M. A. ;
Rakha, E. ;
Ellis, I. O. ;
Liu, S. ;
Gao, D. ;
Nielsen, T. O. ;
Pharoah, P. D. P. ;
Caldas, C. .
ANNALS OF ONCOLOGY, 2014, 25 (08) :1536-1543
[2]   Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer [J].
Anitei, Maria-Gabriela ;
Zeitoun, Guy ;
Mlecnik, Bernhard ;
Marliot, Florence ;
Haicheur, Nacilla ;
Todosi, Ana-Maria ;
Kirilovsky, Amos ;
Lagorce, Christine ;
Bindea, Gabriela ;
Ferariu, Dan ;
Danciu, Mihai ;
Bruneval, Patrick ;
Scripcariu, Viorel ;
Chevallier, Jean-Marc ;
Zinzindohoue, Franck ;
Berger, Anne ;
Galon, Jerome ;
Pages, Franck .
CLINICAL CANCER RESEARCH, 2014, 20 (07) :1891-1899
[3]   CD8+tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG) [J].
Balermpas, Panagiotis ;
Roedel, Franz ;
Roedel, Claus ;
Krause, Mechthild ;
Linge, Annett ;
Lohaus, Fabian ;
Baumann, Michael ;
Tinhofer, Inge ;
Budach, Volker ;
Gkika, Eleni ;
Stuschke, Martin ;
Avlar, Melanie ;
Grosu, Anca-Lidia ;
Abdollahi, Amir ;
Debus, Juergen ;
Bayer, Christine ;
Stangl, Stefan ;
Belka, Claus ;
Pigorsch, Steffi ;
Multhoff, Gabriele ;
Combs, Stephanie E. ;
Moennich, David ;
Zips, Daniel ;
Fokas, Emmanouil .
INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (01) :171-181
[4]   HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer [J].
Barnes, Tristan A. ;
Amir, Eitan .
BRITISH JOURNAL OF CANCER, 2017, 117 (04) :451-460
[5]   The immune landscape of human tumors Implications for cancer immunotherapy [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Angell, Helen K. ;
Galon, Jerome .
ONCOIMMUNOLOGY, 2014, 3 (01)
[6]   X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[7]   Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma [J].
Cho, Young-Ah ;
Yoon, Hye-Jung ;
Lee, Jae-Il ;
Hong, Sam-Pyo ;
Hong, Seong-Doo .
ORAL ONCOLOGY, 2011, 47 (12) :1148-1153
[8]   Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: Prognostic impact may depend on type of treatment and stage of disease [J].
Distel, Luitpold V. ;
Fickenscher, Rainer ;
Dietel, Katrin ;
Hung, Alexander ;
Iro, Heiner ;
Zenk, Johannes ;
Nkenke, Emeka ;
Buettner, Maike ;
Niedobitek, Gerald ;
Grabenbauer, Gerhard G. .
ORAL ONCOLOGY, 2009, 45 (10) :E167-E174
[9]   Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer [J].
Donnem, T. ;
Kilvaer, T. K. ;
Andersen, S. ;
Richardsen, E. ;
Paulsen, E. E. ;
Hald, S. M. ;
Al-Saad, S. ;
Brustugun, O. T. ;
Helland, A. ;
Lund-Iversen, M. ;
Solberg, S. ;
Gronberg, B. H. ;
Wahl, S. G. F. ;
Helgeland, L. ;
Flotten, O. ;
Pohl, M. ;
Al-Shibli, K. ;
Sandanger, T. M. ;
Pezzella, F. ;
Busund, L. T. ;
Bremnes, R. M. .
ANNALS OF ONCOLOGY, 2016, 27 (02) :226-232
[10]   Multiparametric immune profiling in HPV-oral squamous cell cancer [J].
Feng, Zipei ;
Bethmann, Daniel ;
Kappler, Matthias ;
Ballesteros-Merino, Carmen ;
Eckert, Alexander ;
Bell, R. Bryan ;
Cheng, Allen ;
Bui, Tuan ;
Leidner, Rom ;
Urba, Walter J. ;
Johnson, Kent ;
Hoyt, Clifford ;
Bifulco, Carlo B. ;
Bukur, Juergen ;
Wickenhauser, Claudia ;
Seliger, Barbara ;
Fox, Bernard A. .
JCI INSIGHT, 2017, 2 (14)